Advance Therapeutics for Chronic Kidney Disease
Vifor joins forces with Evotec on kidney disease joint venture
Smartphone screening project for kidney disease launched in the Netherlands
Otsuka has high hopes for its ‘drug creation engine’ acquisition
After manufacturing issues, AstraZeneca hopes for FDA nod soon.
EU approves AZ’s potential blockbuster hyperkalaemia drug
Deal is result of six-year collaboration with AZ
AZ signs kidney drug deal with Ionis for up to $330m
Soliris fails when used to treat post-transplant complications.
Alexion drug fails in kidney transplant trial
Daprodustat is potential treatment for anaemia with CKD.
GSK begins phase 3 trials of kidney drug
Spain’s Sanifit chasing calcium disorder blockbuster